Skip to main content

CHARLES SCHWAB INVESTMENT MANAGEMENT INC

Position in DNLI — Denali Therapeutics Inc.

CIK 884546 SAN FRANCISCO, CA

Position in DNLI

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$23,182,060
+$3,362,218 QoQ
Shares Held
1,207,399
+0.6% QoQ
Ownership
0.761%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 99.99610733485783.ToString("F0")% Shared 0.ToString("F0")% None 0.0038926651421775237.ToString("F0")%

Common Shares in DNLI Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,181,979,796 across 287 Biotechnology names. DNLI ranks #55 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in DNLI

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $23,182,060 1,207,399
2025-12-31 $19,819,842 1,200,475
2025-09-30 $16,718,095 1,151,384
2025-06-30 $14,773,705 1,056,019
2025-03-31 $13,729,536 1,009,896
2024-12-31 $20,960,055 1,028,462
2024-09-30 $29,590,545 1,015,810
2024-06-30 $24,597,038 1,059,304
2024-03-31 $21,362,530 1,041,059
2023-12-31 $21,610,155 1,006,997
2023-09-30 $20,239,247 981,059
2023-06-30 $25,603,790 867,631
2023-03-31 $19,268,997 836,328
2022-12-31 $23,267,876 836,673
2022-09-30 $22,430,707 730,880
2022-06-30 $21,528,692 731,522
2022-03-31 $22,655,754 704,251
2021-12-31 $31,986,674 717,190
2021-09-30 $35,504,288 703,752
2021-06-30 $50,219,954 640,234
2021-03-31 $32,290,963 565,516
2020-12-31 $41,310,264 493,198
2020-09-30 $17,429,145 486,440
2020-06-30 $11,394,728 471,246
2020-03-31 $7,330,946 418,672